New Study Shows Strong Growth in Narcolepsy Market with a CAGR of 9.5% And Revenue of US$ 4,537.9 million During 2019-2027

The "Narcolepsy Market Forecast to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Narcolepsy market with detailed market segmentation by indication, drug type, and route of administration and distribution channel. The Narcolepsy Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Narcolepsy Market and offers key trends and opportunities in the market.

The global narcolepsy market size is estimated to reach US$ 4,537.9 million by 2027 from US$ 2,026.8 million in 2018; it is estimated to grow at a CAGR of 9.5% during 2019-2027.

To Remain 'Ahead' Of Your Competitors, Request for A Sample - https://www.theinsightpartners.com/sample/TIPRE00003326/?utm_source=OpenPR&utm_medium=10741

The report makes inclusion of vital information such as market size, growth rate, and valuation of each segmental, regional and country level market, and growth opportunities in related niche market segments. This information has been incorporated after a thorough study of primary and secondary sources.

List of Companies operating in this report are:

• Bioprojet
• Teva Pharmaceutical Industries Ltd.
• Jazz Pharmaceuticals, Inc.
• Graymark Healthcare, Inc.
• Arena Pharmaceuticals, Inc.
• Shire (Acquired by Takeda)
• Ligand Pharmaceuticals, Inc.
• Novartis AG
• Mylan N.V.
• Shionogi Inc.

Feel Free to Ask Your Queries At - https://www.theinsightpartners.com/speak-to-analyst/TIPRE00003326/?utm_source=OpenPR&utm_medium=10741

Narcolepsy Market: Segmental Overview

Type-Based Insights
The global narcolepsy market, based on type, is segmented into narcolepsy with cataplexy, narcolepsy without cataplexy, and secondary narcolepsy. The narcolepsy with cataplexy segment held the largest share among the type subsegments in the narcolepsy market in 2018 and is also anticipated to witness a similar trend over the forecast period.

Product-Based Insights

The global market, based on product, is segmented into central nervous system (CNS) stimulants, sodium oxybate, and antidepressants. The sodium oxybate segment held the largest market share in 2018. Several clinical studies have shown that sodium oxybate can reduce feelings of sleepiness as measured by the Epworth Sleepiness Scale. With sodium oxybate, people with narcolepsy generally stay awake longer during the Maintenance of Wakefulness Test, although they still fall asleep faster than normal. Xyrem (sodium oxybate) Oral Solution is a prescription medicine approved by the US Food and Drug Administration (FDA) with an orphan disease designation to treat cataplexy (a condition where patients suddenly lose muscle tone, including voluntary muscle control, while awake) and excessive daytime sleepiness.

Distribution Channel-Based Insights

The global narcolepsy market, based on distribution channel, is divided into hospital pharmacies and retail pharmacies. The hospital pharmacies segment led the market for narcolepsy in 2018.

Essential points covered in Narcolepsy Market report are:-

What will the market size and the growth rate be in 2027?

What are the key growth stimulants of Narcolepsy Market?

What are the key market trends impacting Narcolepsy Market valuation?

What are the challenges to market proliferation?

Who are the key vendors in the Narcolepsy Market?

Which are the leading companies contributing to Narcolepsy Market valuation?

What was the market share held by each region in 2027?

What is the estimated growth rate and valuation of Narcolepsy Market in 2027?

Buy Complete Report Copy at https://www.theinsightpartners.com/buy/TIPRE00003326/?utm_source=OpenPR&utm_medium=10741

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Ankit Mathur

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defence, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

This release was published on openPR.